Dynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 1, 2010, Pages 90-96

  Álvarez, Gonzalo ^a   Tobón, Alberto ^a   Piñeros, Juan Gabriel ^a   Ríos, Alexandra ^a   Blair, Silvia ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMISININ; ARTESUNATE; CHLOROQUINE; FANSIDAR; MEFLOQUINE; PRIMAQUINE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLOMBIA; DRUG EFFICACY; DRUG POTENTIATION; DYNAMICS; FEMALE; FOLLOW UP; GAMETOCYTE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITE SURVIVAL; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; SCHOOL CHILD; SURVIVAL RATE; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ANIMALS; ANTIMALARIALS; ARTEMISININS; CLINICAL PROTOCOLS; COLOMBIA; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; PARASITEMIA; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PRIMAQUINE; TREATMENT OUTCOME;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 77954607505     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0286     Document Type: Article

References (25)

1. WHO-UNICEF, 2005. Roll Back Malaria World Malaria Report. WHO-UNICEF, ed. Geneva: World Health Organization.
2. WHO, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated falciparum Malaria. Geneva: World Health Organization, WHO/CDS/CSR/RMD document. Geneva.
3. Suh KN, Kain KC, Keystone JS, 2004. Malaria. CMAJ 170: 1693-1702.
4. Kremsner PG, Krishna S, 2004. Antimalarial combinations. Lancet 364: 285-294.
5. Orjuela P, Gonzalez I, Osorio L, 2004. Combination therapy as a strategy to prevent antimalarial drug resistance [in Spanish]. Biomedica (Bogota) 24: 423-437.
6. Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V, 2004. Gametocytogenesis: the puberty of Plasmodium falciparum. Malar J 3: 24.
7. Arango E, Alvarez T, Carmona J, Blair S, 2004. Gametocyte levels in response to differing malaria treatments in two municipalities of Colombia [in Spanish]. Biomedica (Bogota) 24: 79-88.
8. Barnes KI, White NJ, 2005. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop 94: 230-240. (Pubitemid 40720329)
9. Fujioka H, Aikawa M, 1999. The malaria parasite and its life-cycle. Wahlgren M, Perlmann P, eds. Malaria: Molecular and Clinical Aspects. Amsterdam: Harwood Academic, 21-36.
10. Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, ter Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ, 1999. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg 60: 1019-1023.
11. Carmona-Fonseca J, 2004. La malaria en Colombia, Antioquia y las zonas de Urabá y Bajo Cauca: panorama para interpreter la falla terapéutica antimalárica. Parte 2. Iatreia 17: 34-53. (Pubitemid 38639266)
12. Dirección Seccional de Salud de Antioquia, Eventos en Salud Pública. Serie Infeccosas, 1998-2007. Available at: http://www .dssa.gov.co/index.php/estadisticas/eventos-de-salud-publica. Accessed February 26, 2010.
13. Montoya L, Maestre A, Carmona J, Lopes D, Do Rosario V, Blair S, 2003. Plasmodium falciparum: diversity studies of isolates from two Colombian regions with different endemicity. Exp Parasitol 104: 14-19. (Pubitemid 41123181)
14. Montoya P, Tobón A, Blair S, Carmona J, Maestre A, 2007. Polymorphisms of the pfmdr1 gene in field samples of Plasmodium falciparum and their association with therapeutic response to antimalarial drugs and severe malaria in Colombia. Biomedica (Bogota) 27: 204-215.
15. Restrepo E, Carmona-Fonseca J, Maestre A, 2008. Plasmodium falciparum: high frequency of pfcrt point mutations and emergence of new mutant haplotypes in Colombia. Biomedica (Bogota) 28: 523-530.
16. López-Antuñano FJ, 1988. Diagnostico microscópico de los parásites de la malaria en la sangre. López-Antuñano FJ, ed. Diagnosis de Malaria. Washington: Pan-American Health Organization, 39-50.
17. von Seidlein L, Jawara M, Coleman R, Doherty T, Walraven G, Targett G, 2001. Parasitemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop Med Int Health 6: 92-98.
18. Bousema JT, Gouagna LC, Drakeley CJ, Meutstege AM, Okech BA, Akim IN, Beier JC, Githure JI, Sauerwein RW, 2004. l. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J 3: 18.
19. El-Sayed B, El-Zaki SE, Babiker H, Gadalla N, Ageep T, Mansour F, Baraka O, Milligan P, Babiker A, 2007. A randomized open- label trial of artesunate-sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan. PLoS One 2: e1311.
20. Carmona-Fonseca J, Alvarez G, Maestre A, 2009. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment. Am J Trop Med Hyg 80: 188-193.
21. Carmona-Fonseca J, Alvarez G, Rios A, Vasquez MF, 2008. Deficiencia de glucosa 6-fostato deshidrogenasa en hombres sanos y en pacientes maláricos; Turbo (Antioquia, Colombia). Rev Bras Epidemiol 11: 252-265.
22. Baird JK, Hoffman SL, 2004. Primaquine therapy for malaria. Clin Infect Dis 39: 1336-1345.
23. Von Seidlein L, Drakeley C, Greenwood B, Walraven G, Targett G, 2001. Risk factors for gametocyte carriage in Gambian children. Am J Trop Med Hyg 65: 523-527.
24. Beutler E, 1997. Glucose-6-phospate dehydrogenase deficiency: diagnosis, clinical and genetic implications. Am J Clin Pathol 47: 303-311.
25. Stepniewska K, Price RN, Sutherland CJ, Drakeley CJ, von Seidlein L, Nosten F, White NJ, 2008. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar J 7: 249.